BREAKING NEWS APRIL 15, 2026 - In a welcome announcement to the SSRP community, the FDA reported today that it will imminently remove the following bulk drug substances from category 2: BPC-157, LL-37, DiHexa, DSIP, Epitalon, *GHK-Cu (injectable only), KPV, PEG-MGF, Melanotan II, MOTs-C, Semax, and TB-500
BPC157 + TB500 is a combination of two synthetic peptides utilized in controlled laboratory research
However, their homes and livelihoods are increasingly threatened by two factors: government-led initiatives to consolidate fragmented farmland for industrial-scale food production and real estate-driven urban village redevelopment projects, which replace affordable housing and informal markets
The calculator interface may satisfy calculator-page expectations
Step 2 Review Kit Options Choose from available kit options after completing the online intake